Clinical trials for advancing innovative interventions for neurodegenerative diseases[E8]

Del anuncio

Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases. The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond. The scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR [1] principles, thereby encouraging further use of the data. Policymakers, funders, scientific and clinical communities, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches. Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for…[E3]

Los datos del anuncio se muestran tal como los publicó la fuente. Los datos y requisitos que extraemos están en inglés.

• Abierta aUniversities and research. Etiquetado por SLETOR a partir del texto de la convocatoria.
• CondiciónEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RiesgoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• DesconocidoWe read the funder's listing, not the full guidance or application forms.

1. Abierta a ofertas · 29 oct 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Cambios: status, notice type, published at (registro de origen Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage))

2. Vista por primera vez · 28 oct 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Registro de origen: Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage)

Cada dato de esta página procede de la convocatoria del financiador. Cada entrada muestra el registro y el campo del que se leyó.

1. E1

   The funder is European Commission.

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/type/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/deadlineDate/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/descriptionByte/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/type/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

5. E5

   This is an EU call for proposals.

   “31094502”

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/status/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/startDate/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/status/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

8. E8

   The notice is titled "Clinical trials for advancing innovative interventions for neurodegenerative diseases".

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/title/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

9. E9

   The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).

   De Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/budgetOverview/0, leído 29 oct 2026, 07:41 UTC · fuente ↗ (se abre en una pestaña nueva)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licencia de datos: Creative Commons Attribution 4.0 (European Commission) ↗ (se abre en una pestaña nueva). No guardamos ni mostramos los datos de contacto personales de los anuncios.